GR1007341B - Διαγνωστικος προσδιορισμος - Google Patents
Διαγνωστικος προσδιορισμοςInfo
- Publication number
- GR1007341B GR1007341B GR20100100240A GR20100100240A GR1007341B GR 1007341 B GR1007341 B GR 1007341B GR 20100100240 A GR20100100240 A GR 20100100240A GR 20100100240 A GR20100100240 A GR 20100100240A GR 1007341 B GR1007341 B GR 1007341B
- Authority
- GR
- Greece
- Prior art keywords
- target molecule
- binding
- molecules
- sample
- biological sample
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
- G01N2800/285—Demyelinating diseases; Multipel sclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Food Science & Technology (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Rehabilitation Therapy (AREA)
- Rheumatology (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Μέθοδος για την ανίχνευση της παρουσίας ενός μορίου-στόχου σε ένα βιολογικό δείγμα από ένα άτομο, όπου το μόριο στόχος είναι ικανό να συνδέεται με ένα μόριο δεσμεύσεως, όπου η μέθοδος περιλαμβάνει τα στάδια: a) της υποβολής του βιολογικού δείγματος σε ένα στάδιο καθαρισμού για την παροχή ενός εμπλουτισμένου σε μόριο στόχο δείγματος, όπου το στάδιο καθαρισμού περιλαμβάνει: i) την επαφή του βιολογικού δείγματος με μόρια δεσμεύσεως για να επιτραπεί η σύνδεση των μορίων στόχων με τα μόρια δεσμεύσεως, και ii) την απομάκρυνση των μορίων στόχων από τα μόρια δεσμεύσεως για την παροχή του εμπλουτισμένου δείγματος μορίων στόχων- και b) της υποβολής του εμπλουτισμένου δείγματος μορίων στόχων σε μια δοκιμασία για την ανίχνευση της παρουσίας του μορίου στόχου.
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GR20100100240A GR1007341B (el) | 2010-04-21 | 2010-04-21 | Διαγνωστικος προσδιορισμος |
EP11724450A EP2561358A2 (en) | 2010-04-21 | 2011-04-18 | Diagnostic assay |
PCT/IB2011/001014 WO2011132077A2 (en) | 2010-04-21 | 2011-04-18 | Diagnostic assay |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GR20100100240A GR1007341B (el) | 2010-04-21 | 2010-04-21 | Διαγνωστικος προσδιορισμος |
Publications (1)
Publication Number | Publication Date |
---|---|
GR1007341B true GR1007341B (el) | 2011-07-05 |
Family
ID=44510129
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GR20100100240A GR1007341B (el) | 2010-04-21 | 2010-04-21 | Διαγνωστικος προσδιορισμος |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP2561358A2 (el) |
GR (1) | GR1007341B (el) |
WO (1) | WO2011132077A2 (el) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102011011280A1 (de) * | 2011-02-15 | 2012-08-16 | Euroimmun Medizinische Labordiagnostika Ag | Diagnosekit sowie ein Verfahren zur Untersuchung einer menschlichen Patientenprobe auf das Vorhandensein von Neuromyelitis-optica-spezifischen Antikörpern |
DE102014226663A1 (de) * | 2014-12-19 | 2016-06-23 | Charité Universitätsmedizin Berlin | Brückenassays zum Nachweis von Antikörpern gegen Mitglieder der kardialen Rezeptorfamilie |
EP3769083A1 (en) | 2018-03-21 | 2021-01-27 | Waters Technologies Corporation | Non-antibody high-affinity-based sample preparation, sorbents, devices and methods |
CN114487448B (zh) * | 2022-01-21 | 2022-10-18 | 天津天海新域生物科技有限公司 | 用于检测重症肌无力相关抗体的组合物、试剂盒及应用 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4033722A (en) | 1975-08-08 | 1977-07-05 | The Salk Institute For Biological Studies | Assay for myasthenia gravis |
US4789640A (en) * | 1986-01-06 | 1988-12-06 | The Salk Institute For Biological Studies | Assays for myasthenia gravis |
GB0014878D0 (en) | 2000-06-16 | 2000-08-09 | Isis Innovation | Neurotransmission disorders |
US7101679B2 (en) | 2003-11-25 | 2006-09-05 | Mayo Foundation For Medical Education And Research | Marker for neuromyelitis optica |
-
2010
- 2010-04-21 GR GR20100100240A patent/GR1007341B/el active IP Right Grant
-
2011
- 2011-04-18 EP EP11724450A patent/EP2561358A2/en not_active Withdrawn
- 2011-04-18 WO PCT/IB2011/001014 patent/WO2011132077A2/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2011132077A3 (en) | 2012-05-18 |
EP2561358A2 (en) | 2013-02-27 |
WO2011132077A2 (en) | 2011-10-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2576833A4 (en) | METHOD AND DEVICE FOR THE POINT-OF-CARE DETECTION OF NUCLEIC ACID IN A SAMPLE | |
CL2011002228A1 (es) | Aparato para el analisis integrado de acidos nucleicos en tiempo real, y metodo de detecicion de dichas moleculas. | |
WO2011116006A3 (en) | A rapid method to measure cyanide in biological samples | |
WO2013050881A3 (en) | Direct nucleic acid analysis | |
WO2014028378A3 (en) | Methods and systems for detecting biological components | |
MY173921A (en) | A biosensor and preparation method thereof | |
WO2013040435A3 (en) | Molecular diagnostic assay device and method of use | |
WO2005103298A3 (en) | Method for detecting ncrna | |
WO2011022093A3 (en) | Methods and devices for detecting the presence of an analyte in a sample | |
WO2012162165A3 (en) | Antibodies to 25-hydroxyvitamin d2 and d3 and uses thereof | |
AU2012262364A8 (en) | Systems and methods for genetic and biological analysis | |
WO2011100708A3 (en) | Assay card for sample acquisition, treatment and reaction | |
WO2011136624A3 (ko) | 자기장 인가부를 구비한 생물학적 시료 자동정제장치, 생물학적 시료로부터 타겟물질을 추출하는 방법, 그리고 단백질 발현 및 정제 방법 | |
WO2011063332A3 (en) | Microwell array articles and methods of use | |
WO2009060847A1 (ja) | 核酸増幅用サンプルの調製方法及び調製キット | |
EA201291396A1 (ru) | Способ детекции молекулярных взаимодействий | |
WO2011121454A3 (en) | Direct nucleic acid analysis | |
EP2254897A4 (en) | METHOD, REAGENTS AND KITS FOR DETECTING NUCLEIC ACID MOLECULES | |
MX2014006118A (es) | Deteccion de analitos. | |
BR112012024206A2 (pt) | método e sistema para analisar uma amostra de sangue | |
BRPI0916111A2 (pt) | cubeta para armazenar uma amostra biol[ogica a ser analisada por meio de uma técnica de detecção pré definida, método para a fabricação de uma cubeta, método para autenticar uma cubeta, método para analisar uma amostra biológica e sistema para analisar uma amostra biológica | |
WO2009126848A3 (en) | Analyzing large data sets using a computer system | |
EP2504348A4 (en) | METHODS, REAGENTS AND KITS FOR DETECTING NUCLEIC ACID MOLECULES | |
WO2009034842A1 (ja) | 核酸検出方法、および核酸検出キット | |
GB201206977D0 (en) | An enzyme detection device |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PG | Patent granted |
Effective date: 20110829 |